glp 1 for migraines Study finds GLP-1 drug cut migraine frequency by nearly half Treatment with GLP-1 receptor agonists

This suggests that tirzepatide is more effective in improving glucose control in patients with T2DM [87, 88]

Clinical data so far have shown that retatrutide dose-dependently increases heart rate up to 6.7 bpm at 24 weeks and declined thereafter (83) while pulse rate increased with increasing doses of tirzepatide peaking (6.6

This may occur because the drug delays gastric emptying

April 10, 2024

Current clinical evidence does not show that GLP-1 therapy directly triggers or worsens autoimmune thyroid destruction, but the relationship between metabolic change and immune function remains an area of active research

What does United Healthcare cover for weight loss